Transport Proteins: Volume 123

ISBN-13: 9780128220870 / Angielski / Twarda / 2021 / 286 str.

Rossen Donev

Spis treści

1. Biology of the iron efflux transporter, ferroportin
Gautam Rishi and V. Nathan Subramaniam
2. The effect of sport and physical activity on transport proteins: implications for cancer prevention and control
Maha Sellami and Nicola Luigi Bragazzi
3. Cancer bioenergetics as emerging holistic cancer theory: the role of metabolic fluxes and transport proteins involved in metabolic pathways in the pathogenesis of malignancies. State-of-the-art and future prospects
Nicola Luigi Bragazzi and Maha Sellami
4. Investigating mutations at the hotspot position of the ERBB2 and screening for the novel lead compound to treat breast cancer - a computational approach
D. Thirumal Kumar, S. Udhaya Kumar, R. Magesh and C. George Priya Doss
5. Autophagy proteins and its homeostasis in cellular environment
Vrushali Guhe, Bhavnita Soni, Prajakta Ingale and Shailza Singh
6. Expression of placental glucose transporter proteins in pregnancies complicated by fetal growth disorders
Pawel Jan Stanirowski, Michal Lipa, Dorota Bomba-Opo and Miroslaw Wielgos
7. The role of transferrins and iron-related proteins in brain iron transport: applications to neurological diseases
Camila Campos-Escamilla
8. ABCG: a new fold of ABC exporters and a whole new bag of riddles!
Atanu Banerjee, Alexis Moreno, Jorgaq Pata, Pierre Falson and Rajendra Prasad
9. Serum albumin: clinical significance of drug binding and development as drug delivery vehicle
Saad Tayyab and Shevin Rizal Feroz
10. PTR2/POT/NPF transporters: what makes them tick?
Bala K. Prabhala, Moazur Rahman, Hussam H. Nour-eldin and Flemming Steen Jørgensen and Osman Mirza
11. Network analysis of transcriptomics data for the prediction and prioritization of membrane-associated biomarkers for idiopathic pulmonary fibrosis (IPF) by bioinformatics approach
Smriti Mishra, Mohammad Imran Shah, S. Udhaya Kumar, D. Thirumal Kumar, Chandrasekhar Gopalakrishnan, Abeer Mohammed Al-Subaie, R. Magesh, C. George Priya Doss and Balu Kamaraj

O autorze

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.